a<p>higher expression in subgroup of PCLBCL.</p><p>PCFCL: primary cutaneous follicle center lymphoma; PCLBCL-LT: primary cutaneous diffuse large B-cell lymphoma, leg type.</p
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Lymphoma is a prevalent malignancy in dogs. Diffuse large B-cell Lymphoma (DLBCL) is the common subt...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
<div><p>Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal...
MicroRNAs are naturally occurring small RNA species that regulate gene expression and are frequently...
The oncogenic microRNA (miR) 17–92 cluster has a causative role in the lymphomagenesis of nodal B-ce...
We studied the global miRNA expression in diffuse large B-cell lymphoma (DLBCL; n=79), Burkitt lymph...
Diffuse large B-cell lymphoma (DLBCL) can present as de novo or can arise through the transformation...
Item does not contain fulltextTwo distinct primary cutaneous large B cell lymphomas are recognized: ...
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whos...
Long non‐coding RNAs (lncRNAs) comprise a family of non‐coding transcripts that are emerging as rele...
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whos...
Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHO...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Lymphoma is a prevalent malignancy in dogs. Diffuse large B-cell Lymphoma (DLBCL) is the common subt...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
<div><p>Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal...
MicroRNAs are naturally occurring small RNA species that regulate gene expression and are frequently...
The oncogenic microRNA (miR) 17–92 cluster has a causative role in the lymphomagenesis of nodal B-ce...
We studied the global miRNA expression in diffuse large B-cell lymphoma (DLBCL; n=79), Burkitt lymph...
Diffuse large B-cell lymphoma (DLBCL) can present as de novo or can arise through the transformation...
Item does not contain fulltextTwo distinct primary cutaneous large B cell lymphomas are recognized: ...
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whos...
Long non‐coding RNAs (lncRNAs) comprise a family of non‐coding transcripts that are emerging as rele...
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whos...
Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHO...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Lymphoma is a prevalent malignancy in dogs. Diffuse large B-cell Lymphoma (DLBCL) is the common subt...
DOI
Add to ORKG